Plain-English translation of NCT04190589 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Colorectal Cancer research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether robot-assisted surgery can perform as well as traditional open surgery for treating colon cancer located in the right side or transverse (middle) part of the colon. The robot-assisted approach uses smaller incisions and more precise instruments, which may mean less pain, fewer complications, and a faster recovery compared to traditional open surgery. Researchers want to make sure the robotic method removes the cancer just as effectively while offering patients these potential benefits.
Currently, most surgeons prefer traditional open surgery for this type of colon cancer because the robotic approach is very technically challenging in this location. However, robotic and minimally invasive surgery generally help patients recover faster with less pain and shorter hospital stays. This trial exists to prove that robot-assisted surgery can safely deliver the same cancer-fighting results with these recovery benefits.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will receive robot-assisted extended right colectomy—a surgical procedure where your surgeon uses a robotic system to remove the affected part of your colon through small incisions. The researchers will then compare how well your surgery went, your recovery, and any complications you experience with a group of patients who had the same surgery performed traditionally with one large open incision. You will be followed to track your healing, pain levels, how long you stay in the hospital, and the quality of the tissue removed during surgery.
AI-generated summary from trial data · Jun 12, 2026 · Not medical advice
Denmark